Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains

Veterinary Immunology and Immunopathology

Volumn 143, Issue 1-2, 2011, Pages 116-124

  Wagner, Bettina ^a   Wimer, Christine ^a   Freer, Heather ^a   Osterrieder, Nikolaus ^b   Erb, Hollis N ^a  

^a Department of Obstetrics Gynecology   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Cytokine; Herpesvirus; Horse; Innate immune response; Neonate; Pregnancy

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; EQUINE HERPES VIRUS; FEMALE; HERPES VIRUS INFECTION; IN VITRO STUDY; INNATE IMMUNITY; MARE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; REINFECTION; VIRUS REACTIVATION; VIRUS VIRULENCE;

ANIMALS; ANIMALS, NEWBORN; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HORSE DISEASES; HORSES; IMMUNE TOLERANCE; INTERFERON-ALPHA; INTERLEUKIN-10; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SPECIES SPECIFICITY;

EQUID HERPESVIRUS 1; EQUIDAE; HERPESVIRIDAE;

EID: 79961025904     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.06.032     Document Type: Article

References (60)

1. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van Dyke T., Pulendran B. Cutting edge: different toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 2003, 171:4984-4989.
2. Allen G., Yeargan M., Costa L.R., Cross R. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J. Virol. 1995, 69:606-612.
3. Allen G.P. Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses. Am. J. Vet. Res. 2008, 69:1595-1600.
4. APHIS Equine Herpesvirus Myeloencephalopathy: a Potentially Emerging Disease 2007, http://www.aphis.usda.gov/animal_health/emergingissues/downloads/ehv1final.pdf.
5. Boonstra A., Rajsbaum R., Holman M., Marques R., Asselin-Paturel C., Pereira J.P., Bates E.E., Akira S., Vieira P., Liu Y.J., Trinchieri G., O'Garra A. Macrophages and myeloid dendritic cells, but not plasmacytoiddendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J. Immunol. 2006, 177:7551-7558.
6. Breathnach C.C., Soboll G., Suresh M., Lunn D.P. Equine herpesvirus-1 infection induces IFN-g production by equine T lymphocyte subsets. Vet. Immunol. Immunopathol. 2005, 103:207-215.
7. Cheeran M.C., Hu S., Palmquist J.M., Bakken T., Gekker G., Lokensgard J.R. Dysregulated interferon-gamma responses during lethal cytomegalovirus brain infection of IL-10-deficient mice. Virus Res. 2007, 130:96-102.
8. Coombs D.K., Patton T., Kohler A.K., Soboll G., Breathnach C., Townsend H.G., Lunn D.P. Cytokine responses to EHV-1 infection in immune and non-immune ponies. Vet. Immunol. Immunopathol. 2006, 111:109-116.
9. Crowhurst F.A., Dickinson G., Burrows R. An outbreak of paresis in mares and geldings associated with equine herpesvirus-1. Vet. Rec. 1981, 109:527-528.
10. Edington N., Bridges C.G., Patel J.R. Endothelial cell infection and thrombosis in paralysis induced by equid herpesvirus-1: equine stroke. Arch. Virol. 1986, 90:111-124.
11. Foote C.E., Love D.N., Gilkerson J.R., Whalley J.M. Detection of EHV-1 and EHV-4 DNA in unweaned Thoroughbred foals from vaccinated mares on a large stud farm. Equine Vet. J. 2004, 36:341-345.
12. Fuijo K., Okamura T., Yamamoto K. The family of IL-10 secreting CD4+ T cells. Adv. Immunol. 2010, 105:99-130.
13. Gilkerson J., Love D., Drummer H., Studdert M., Whalley J. Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997. Vet. Microbiol. 1999, 68:15-25.
14. Goehring L.S., van Winden S.C., van Maanen C., Sloet van Oldruitenborgh-Oosterbaan M.M. Equine herpesvirus type 1-associated myeloencephalopathy in The Netherlands: a four-year retrospective study (1999-2003). J. Vet. Intern. Med. 2006, 20:601-607.
15. Henninger R.W., Reed S.M., Saville W.J., Allen G.A., Hass G.F., Kohn C.W., Sofaly C. Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center. J. Vet. Intern. Med. 2007, 21:157-161.
16. Hu X., Paik P.K., Chen J., Yarilina A., Kockeritz L., Lu T.T., Woodgett J.R., Ivashkiv L.B. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 2006, 24:563-574.
17. Ito T., Wang Y.H., Liu Y.J. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin. Immunopathol. 2005, 26:221-229.
18. Jacks S., Giguère S., Crawford P.C., Castleman W.L. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin. Vaccine Immunol. 2007, 14:669-677.
19. Johnson A.J., Chu C.F., Milligan G.N. Effector CD4+ T-cells involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords. J. Virol. 2008, 82:9678-9688.
20. Jung A., Kato H., Kumagai Y., Kumar H., Kawai T., Takeuchi O., Akira S. Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88. J. Virol. 2008, 82:196-206.
21. Kohn C.W., Reed S.M., Sofaly C.D., Henninger R.W., Saville W.J., Allen G.P., Premanadan C. Transmission of EHV -1 in horses with EHV -1 myeloencephalopathy: implications for biosecurity and review. Clin. Tech. Equine Pract. 2006, 5:60-66.
22. Krug A., Luker G.D., Barchet W., Leib D.A., Akira S., Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004, 103:1433-1437.
23. Kurt-Jones E.A., Chan M., Zhou S., Wang J., Reed G., Bronson R., Arnold M.M., Knipe D.M., Finberg R.W. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:1315-1320.
24. Kydd J., Smith K.C., Hannant D., Livesay G.J., Mumford J.A. Distribution of equid herpesvirus-1 (EHV-1) in the respiratory tract associated lymphoid tissue: implications for cellular immunity. Equine Vet. J. 1994, 26:470-473.
25. Kydd J.H., Wattrang E., Hannant D. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet. Immunol. Immunopathol. 2003, 96:207-217.
26. Kydd J.H., Townsend H.G., Hannant D. The equine immune response to equine herpesvirus-1: the virus and its vaccines. Vet. Immunol. Immunopathol. 2006, 111:15-30.
27. Lund J., Sato A., Akira S., Medzhitov R., Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 2003, 198:513-520.
28. Lunn D.P., Davis-Poynter N., Flaminio M.J., Horohov D.W., Osterrieder K., Pusterla N., Townsend H.G. Equine herpesvirus-1 consensus statement. J. Vet. Intern. Med. 2009, 23:450-461.
29. Malmgaard L. Induction and regulation of IFNs during viral infection. J. Interferon Cytokine Res. 2004, 24:439-454.
30. Marshall E.E., Gaballe A.P. Multifaceted evasion of the interferon response by cytomegalovirus. J. Interferon Cytokine Res. 2009, 29:609-619.
31. Mescher M.F., Curtsinger J.M., Agarwal P., Casey K.A., Gerner M., Hammerbeck C.D., Xiao Z. Signal required for programming effector and memory development by CD8+ T cells. Immunol. Rev. 2006, 211:81-92.
32. Min B., Prout M., Hu-Li J., Zhu J., Jankovic D., Morgan E.S., Urban J.F., Dvorak A.M., Finkelman F.D., LeGros G., Paul W.E. Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J. Exp. Med. 2004, 200:507-517.
33. Mitre E., Taylor R.T., Kubofcik J., Nutman T.B. Parasite antigen-driven basophils are a major source of IL-4 in human filarial infections. J. Immunol. 2004, 172:2439-2445.
34. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
35. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7:145-173.
36. Niessner A., Sato K., Chaikof E.L., Colmegna I., Goronzy J.J., Weyand C.M. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in an atherosclerotic plaque through interferon-alpha. Circulation 2006, 114:2482-2489.
37. O'Garra A., Barrat F.J., Castro A.G., Vicari A., Hawrylowicz C. Strategies for the use of IL-10 or its antagonists in human disease. Immunol. Rev. 2008, 223:114-131.
38. Paillot R., Daly J.M., Juillard V., Minke J.M., Hannant D., Kydd J.H. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Vaccine 2005, 23:4541-4551.
39. Paillot R., Ellis S.A., Daly J.M., Audonnet J.C., Minke J.M., Davis-Poynter N., Hannant D., Kydd J. Characterisation of CTL and IFN-γ synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Vaccine 2006, 24:1490-1500.
40. Paillot R., Daly J.M., Luce R., Montesso F., Davis-Poynter N., Hannant D., Kydd J.H. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesizing lymphocytes in ponies: the effects of age, pregnancy and infection. Dev. Comp. Immunol. 2007, 31:202-214.
41. Paladino P., Mossman K.L. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J. Interferon Cytokine Res. 2009, 29:599-607.
42. Patel J.R., Heldens J. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)-epidemiology, disease and immunoprophylaxis: a brief review. Vet. J. 2005, 170:14-23.
43. Perkins G.A., Goodman L.B., Tsujimura K., Van de Walle G.R., Kim S.G., Dubovi E.J., Osterrieder N. Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984-2007). Vet. Microbiol. 2009, 139:375-378.
44. Pusterla N., Wilson W.D., Conrad P.A., Barr B.C., Ferraro G.L., Daft B.M., Leutenegger C.M. Cytokine gene signatures in neural tissue of horses with equine protozoalmyeloencephalitis or equine herpes type 1 myeloencephalopathy. Vet. Rec. 2006, 159:341-346.
45. Rebenko-Molla N., Liua L., Cardona A., Ransohoff R. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr. Opin. Immunol. 2006, 18:683-689.
46. Roizman B. Herpesviridae. Virology 1996, 2221-2230. Lippincott-Raven Press, Philadelphia, New York. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
47. Roizman B., Sears A.E. Herpes simplex viruses and their replication. Virology 1996, 2231-2295. Lippincott-Raven Press, Philadelphia, New York. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
48. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
49. Sato A., Linehan M.M., Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17343-17348.
50. Slater J.D., Borchers K., Thackray A.M., Field H.J. The trigeminal ganglion is a location for equine herpesvirus1 latency and reactivation in the horse. J. Gen. Virol. 1994, 75:2007-2016.
51. Sokol C.L., Barton G.M., Farr A.G., Medzhitov R. A mechanism for the initiation of allergen-induced Thelper type 2 responses. Nat. Immunol. 2008, 9:310-318.
52. Szabo G., Dolganiuc A. The role of plasmacytoid dendritic cell-derived IFN alpha in antiviral immunity. Crit. Rev. Immunol. 2008, 28:61-94.
53. Trinchieri G. Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection. J. Exp. Med. 2001, 194:F53-F57.
54. Van de Walle G.R., Sakamoto K., Osterrieder N. CCL3 and viral chemokine-binding protein gG modulate pulmonary inflammation and virus replication during equine herpesvirus type 1 (EHV-1) infection. J. Virol. 2008, 82:1714-1722.
55. Van de Walle G.R., Maya M.A., Petersa S.T., Metzgera S.M., Rosasa C.T., Osterrieder N. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus. Vaccine 2010, 28:1048-1055.
56. Wagner B., Freer H. Development of a bead-based multiplex assay for simultaneous quantification of cytokines in horses. Vet. Immunol. Immunopathol. 2009, 127:242-248.
57. Wagner B., Stokol T., Ainsworth D.M. Induction of interleukin-4 production in neonatal IgE+ cells after crosslinking of maternal IgE. Dev. Comp. Immunol. 2010, 34:436-444.
58. Wagner B., Burton A., Ainsworth D.M. Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals. Vet. Res. 2010, 41:47.
59. Wimer C.L., Damiani A., Osterrieder N., Wagner B. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression. Vet. Immunol. Immunopathol. 2011, 140:266-274.
60. Wuest T., Carr D.J. The role of chemokines during herpes simplex virus-1 infection. Front. Biosci. 2008, 13:4862-4872.